Gratus Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $15M | Buy |
47,852
+1,282
| +3% | +$377K | 0.6% | 52 |
|
|
2024
Q1 | $13.2M | Buy |
46,570
+1,026
| +2% | +$300K | 0.61% | 49 |
|
|
2023
Q4 | $13.1M | Sell |
45,544
-781
| -2% | -$213K | 0.74% | 46 |
|
|
2023
Q3 | $12.5M | Buy |
46,325
+303
| +0.7% | +$75.6K | 0.84% | 37 |
|
|
2023
Q2 | $10.2M | Buy |
46,022
+1,099
| +2% | +$255K | 0.7% | 49 |
|
|
2023
Q1 | $10.9M | Sell |
44,923
-1,100
| -2% | -$270K | 0.83% | 45 |
|
|
2022
Q4 | $12.1M | Buy |
46,023
+43,101
| +1,475% | +$11.6M | 0.99% | 40 |
|
|
2022
Q3 | $659K | Sell |
2,922
-238
| -8% | -$57.7K | 0.07% | 132 |
|
|
2022
Q2 | $769K | Buy |
3,160
+673
| +27% | +$165K | 0.09% | 116 |
|
|
2022
Q1 | $602K | Sell |
2,487
-89
| -3% | -$20.4K | 0.06% | 137 |
|
|
2021
Q4 | $580K | Buy |
2,576
+19
| +0.7% | +$4.01K | 0.05% | 134 |
|
|
2021
Q3 | $544K | Sell |
2,557
-531
| -17% | -$122K | 0.06% | 127 |
|
|
2021
Q2 | $753K | Sell |
3,088
-2,016
| -39% | -$496K | 0.08% | 117 |
|
|
2021
Q1 | $1.27M | Hold |
5,104
| – | – | 0.15% | 108 |
|
|
2020
Q4 | $1.17M | Buy |
5,104
+106
| +2% | +$24.4K | 0.16% | 103 |
|
|
2020
Q3 | $1.27M | Sell |
4,998
-272
| -5% | -$67.4K | 0.2% | 99 |
|
|
2020
Q2 | $1.24M | Sell |
5,270
-334
| -6% | -$76.2K | 0.21% | 94 |
|
|
2020
Q1 | $1.14M | Sell |
5,604
-138
| -2% | -$30.1K | 0.21% | 103 |
|
|
2019
Q4 | $1.38M | Sell |
5,742
-290
| -5% | -$63.9K | 0.21% | 102 |
|
|
2019
Q3 | $1.17M | Sell |
6,032
-408
| -6% | -$78.3K | 0.19% | 103 |
|
|
2019
Q2 | $1.19M | Sell |
6,440
-98
| -1% | -$17.5K | 0.19% | 105 |
|
|
2019
Q1 | $1.24M | Sell |
6,538
-274
| -4% | -$52.3K | 0.21% | 102 |
|
|
2018
Q4 | $1.33M | Buy |
6,812
+352
| +5% | +$68.7K | 0.27% | 95 |
|
|
2018
Q3 | $1.34M | Sell |
6,460
-192
| -3% | -$37.8K | 0.18% | 92 |
|
|
2018
Q2 | $1.23M | Sell |
6,652
-853
| -11% | -$151K | 0.18% | 90 |
|
|
2018
Q1 | $1.28M | Buy |
7,505
+222
| +3% | +$40.8K | 0.18% | 94 |
|
|
2017
Q4 | $1.27M | Sell |
7,283
-251
| -3% | -$44.4K | 0.16% | 101 |
|
|
2017
Q3 | $1.41M | Sell |
7,534
-931
| -11% | -$165K | 0.2% | 94 |
|
|
2017
Q2 | $1.46M | Sell |
8,465
-28,079
| -77% | -$4.57M | 0.21% | 91 |
|
|
2017
Q1 | $6M | Sell |
36,544
-14,931
| -29% | -$2.48M | 0.86% | 33 |
|
|
2016
Q4 | $7.53M | Buy |
51,475
+2,991
| +6% | +$450K | 1.13% | 19 |
|
|
2016
Q3 | $8.09M | Buy |
48,484
+1,498
| +3% | +$253K | 1.18% | 16 |
|
|
2016
Q2 | $7.15M | Buy |
46,986
+8
| +0% | +$1.24K | 1.05% | 19 |
|
|
2016
Q1 | $7.04M | Buy |
46,978
+6,227
| +15% | +$925K | 1.54% | 13 |
|
|
2015
Q4 | $6.62M | Buy |
40,751
+6,461
| +19% | +$1.02M | 1.5% | 8 |
|
|
2015
Q3 | $4.74M | Sell |
34,290
-676
| -2% | -$107K | 1.14% | 18 |
|
|
2015
Q2 | $5.37M | Buy |
34,966
+107
| +0.3% | +$17.1K | 1.25% | 15 |
|
|
2015
Q1 | $5.57M | Buy |
34,859
+4,749
| +16% | +$748K | 1.24% | 14 |
|
|
2014
Q4 | $4.8M | Buy |
+30,110
| New | +$4.69M | 1.14% | 21 |
|
Other funds holding AMGN
Gratus Capital's AMGN Position: Q2 2024 in Review
Gratus Capital increased its Amgen (AMGN) stake by 2.8% in Q2 2024, buying an estimated $377K and bringing the position to 47,852 shares worth $15M. The position accounts for 0.6% of the portfolio, ranked #52.
Gratus Capital first reported a position in AMGN in Q4 2014 and has held it in 39 quarters since. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Gratus Capital held 47,852 shares of Amgen worth $15M as of Q2 2024.
- Gratus Capital bought 1,282 Amgen shares in Q2 2024, an estimated $377K.
- Amgen made up 0.6% of Gratus Capital's portfolio in Q2 2024, its #52 holding.
- Gratus Capital first reported a position in Amgen in Q4 2014 and has held it in 39 quarters since.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.